Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

260-NETWORK CONTRACT OFFICE 20 (36C260)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26026Q0167

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6515

Additional Details
Set Aside

SBA

Place of Performance

Seattle, Washington, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, through the Pathology Laboratory Medicine division at the Seattle VA Medical Center (Seattle VAMC), has issued a solicitation (Procurement Identifier: 36C26026Q0167) seeking to establish a contract for the distribution of BioRad BioPlex laboratory reagents. This procurement is specifically intended to support the automated immunoassay instrumentation needs of the Seattle VAMC, ensuring the facility has reliable access to high-quality reagents necessary for a broad spectrum of diagnostic testing. The scope of this contract encompasses the provision and distribution of immunoassay reagents compatible with the BioRad BioPlex platform. The selected contractor will be responsible for supplying reagents that enable the performance of a comprehensive range of immunoassays, including but not limited to: ANA Screens, Syphilis IgG and RPR, Measles/Mumps/Rubella/Varicella, Herpes Simplex Virus (HSV) antibodies, Cytomegalovirus (CMV) antibodies, Epstein-Barr Virus (EBV) antibodies, Vasculitis Panel, Anti-CCP Panel, Celiac Panels, Antiphospholipid Panels, HIV Antibody Panel, and Toxoplasma. A critical requirement is the vendor’s ability to provide methodology for differentiating between HIV 1 and HIV 2. The contract also allows for the addition of new tests, reagents, or instrumentation as advancements in technology become available, ensuring the laboratory remains at the forefront of diagnostic capabilities. The intended outcome of this procurement is to secure a single, reliable contractor who can consistently meet the Seattle VAMC’s needs for automated immunoassay reagents, thereby supporting the facility’s mission to deliver high-quality diagnostic services to veterans. The contract will be awarded exclusively for use by the Seattle VAMC, as detailed in the solicitation attachments. This opportunity is classified under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022 version) and Product Service Code 6515, indicating a focus on medical and laboratory equipment and supplies. The procurement is set aside for SBA-eligible entities, reflecting the VA’s commitment to supporting small business participation in federal contracting. The place of performance is Seattle, Washington, and the contract will be managed by the 260-Network Contract Office 20 (36C260), a federal office responsible for overseeing procurement activities within the region. Interested parties should direct inquiries to the primary point of contact, Hector Gonzalez, who can be reached at [email protected] or by phone at 360-553-7632. The solicitation was posted on December 12, 2025, with responses due by December 20, 2025. Contractors considering this opportunity should review the solicitation and its attachments via the official SAM.gov listing (Opportunity ID: eeed9459d9d94d4e9955ff08173510aa) for complete requirements and submission instructions. This procurement represents a stable, ongoing need for specialized laboratory reagents and instrumentation support, making it well-suited for contractors with established capabilities in in-vitro diagnostic substance manufacturing and distribution, particularly those with experience supporting automated immunoassay platforms in clinical laboratory environments.